Diversity lacks in Alzheimer’s research, study shows
Nov 03, 2023
A new study examining data on Alzheimer’s drug trials and found the people being studied are largely not representative of people on Medicare. The people who participate in the trials tend to be younger....
Diabetes drugs may have potential to slow Alzheimer’s progression, researchers say
May 09, 2023
Evidence is growing that GLP-1 agonists may be good candidates for testing against neurodegenerative disease.
Study: ‘Cognitive frailty’ may be result of aging — not the brain changes found in dementia
Jan 11, 2022
Reduced cognitive function without substantial memory complaints may be a normal part of aging and not an early sign of Alzheimer’s disease or other dementias, investigators say.
Generic for Viagra holds promise as Alzheimer’s disease treatment, Cleveland Clinic researchers say
Dec 08, 2021
Users of sildenafil are 69% less likely to develop Alzheimer’s disease than their peers who do not use the drug, investigators report. A clinical trial to confirm its benefits for Alzheimer’s patients...
Scientists say they’ve zeroed in on a cause of Alzheimer’s
Dec 03, 2021
Researchers from the University of California, Riverside say they have uncovered a reason why some people with plaques and tangles in their brains do not develop Alzheimer’s disease.
First human trial of nasal vaccine for Alzheimer’s set to begin in Boston
Nov 18, 2021
Sixteen participants with early, symptomatic Alzheimer’s will receive doses of a vaccine containing the immune-modulating drug Protollin. Nasal delivery has shown promise as a way to eliminate beta amyloid...
Alzheimer’s drug designed for ‘at-home’ use scores FDA breakthrough designation
Oct 12, 2021
The experimental Alzheimer’s drug gantenerumab is the “first and only” anti-amyloid antibody being investigated for subcutaneous administration and could potentially be given to patients...
Drugmakers ask FDA to approve another Alzheimer’s drug, similar to Aduhelm
Sep 29, 2021
Drugmakers Eisai and Biogen are putting the Food and Drug Administration to the test with a request to approve a second Alzheimer’s drug that works like aducanumab (Aduhelm), the new, yet controversial,...
Donepezil may help preserve muscle cell functioning in Alzheimer’s
Sep 28, 2021
People with early Alzheimer’s who are treated with the drug donepezil maintain mitochondrial function in their muscles when compared to their untreated peers, researchers report.
A first: Researchers show inflammation is key driver of Alzheimer’s in living patients
Aug 27, 2021
Treatments targeting inflammation could help reverse or at least slow the accumulation of pathologic tau protein in the brain — benefitting people with early dementia, investigators say.